Page last updated: 2024-09-02

oxymatrine and Degenerative Disc Disease

oxymatrine has been researched along with Degenerative Disc Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Ahati, P; Chen, Y; Dai, J; Ding, Q; Ding, Y; Fang, H; Pei, Y; Wang, H; Wang, Z; Wei, K; Zhou, X1
Ding, J; Ding, Y; Fang, H; Pei, Y; Tan, S; Wang, H; Wei, K; Zhang, C; Zhang, W; Zou, C1

Other Studies

2 other study(ies) available for oxymatrine and Degenerative Disc Disease

ArticleYear
Oxymatrine suppresses IL-1β-induced degradation of the nucleus pulposus cell and extracellular matrix through the TLR4/NF-κB signaling pathway.
    Experimental biology and medicine (Maywood, N.J.), 2020, Volume: 245, Issue:6

    Topics: Alkaloids; Animals; Apoptosis; Cells, Cultured; Extracellular Matrix; Interleukin-1beta; Intervertebral Disc Degeneration; Matrix Metalloproteinases; NF-kappa B; Nucleus Pulposus; Quinolizines; Rats; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4

2020
Oxymatrine Liposomes for Intervertebral Disc Treatment: Formulation, in vitro and vivo Assessments.
    Drug design, development and therapy, 2020, Volume: 14

    Topics: Alkaloids; Animals; Apoptosis; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Hydrogen-Ion Concentration; Inflammation; Intervertebral Disc Degeneration; Liposomes; Mice; Mice, Inbred Strains; Molecular Structure; Particle Size; Quinolizines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Surface Properties

2020